Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients
- 15 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 31 (5), 589-592
- https://doi.org/10.1038/s41422-020-00457-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Plasma DNA End-Motif Profiling as a Fragmentomic Marker in Cancer, Pregnancy, and TransplantationCancer Discovery, 2020
- Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinomaGut, 2019
- Genome-wide cell-free DNA fragmentation in patients with cancerNature, 2019
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2019
- Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaCancer Science, 2018
- Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancerJournal of Translational Medicine, 2018
- NucMap: a database of genome-wide nucleosome positioning map across speciesNucleic Acids Research, 2018
- Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million PeopleJournal of Hepatology, 2018
- Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infectionJournal of Hepatology, 2016
- Uncovering the role of 5-hydroxymethylcytosine in the epigenomeNature Reviews Genetics, 2011